• Deals this week: Carma Therapeutics, Vectorite Biomedica, Loxo Oncology pharmaceutical-technology
    June 19, 2017
    Cellular immunotherapies developer Carma Therapeutics has completed a venture financing round co-led by AbbVie Biotech Ventures and HealthCap in order to raise funds required to advance the development of its adoptive cellular immunotherapy named CARMA-05
PharmaSources Customer Service